Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MIRENA
- Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
- Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
- Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
- Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)
- A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore
- Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.
- Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
- IUD and Norethindrone Acetate for Treatment of Endometriosis
- Impact of Contraceptives on Cervico-Vaginal Mucosa
- Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer
- Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia
- Hormonal Contraceptive Methods on Immunologic Changes in the Female Genital Tract (FGT) and Systemically
- Immediate Postpartum Insertion of Contraceptive Intrauterine Devices
- Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
- Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer
- Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia
- A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA)
- Ulipristal Versus Placebo for Women With Bleeding Induced by Mirena
- Mirena Extension Trial
- Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
- To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Furt
- Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis
- Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
- Misoprostol Prior to Intrauterine Contraceptive Device Insertion
- Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer
- Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users
- Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
- Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis
- LNG-IUS at 2 Weeks Postpartum
- Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
- Stopping Heavy Periods Project
- BLIS - Breastfeeding Levonorgestrel IUD Study
- MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS Study
- Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
- Pretreatment With Mifepristone Prior to Mirena Insertion
- Quantification of Immune Cells in Women Using Contraception (CHIC II)
- Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
- Modulation of Mucosal and Systemic Immunity by Hormonal Contraceptives
- Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding
- Improving the Treatment for Women With Early Stage Cancer of the Uterus
- Pain Control for Intrauterine Device Placement: A Trial of Ketorolac Prior to Intrauterine Device Placement
- Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression
- LNG-IUS for Treatment of Dysmenorrhea
- Early Postpartum Intrauterine Device (IUD) Placement
- Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction
- Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding
- Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women
- Topical Lidocaine for Pain Control With Intrauterine Device (IUD) Insertion
- Mirena Post-marketing Surveillance in Japan
- Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding
- Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)
- Topical Lidocaine on the Cervix and Intra-Cervical Prior to Insertion of Intrauterine Devices
- Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women
- Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery
- MiCo - Mirena or Conventional Medical Treatment for Menorrhagia
- A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia
- A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
- Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia
- Acceptability of Long-term Progestin-only Contraception in Europe
- Mirena Observational Program
- Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding
- Mirena in Idiopathic Menorrhagia
- Mirena or Conventional Medical Treatment for Menorrhagia
- Scandinavian Mirena Insertion Nulliparous Trial.
- Mirena Efficiency and Tolerability During the First Year of Use
- HR-QoL and Sexuality in Mirena Inserted Contraception Users
- 'Levonorgestrel IUD Insertion After D&E Procedure
- Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
- Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
- Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
- Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)
Clinical trials list
click for details